Humana Inc. (NYSE:HUM) Shares Bought by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. increased its stake in Humana Inc. (NYSE:HUM) by 12.2% during the third quarter, HoldingsChannel.com reports. The fund owned 14,762 shares of the insurance provider’s stock after buying an additional 1,608 shares during the period. Daiwa Securities Group Inc.’s holdings in Humana were worth $4,676,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of HUM. Mendota Financial Group LLC lifted its stake in Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after buying an additional 27 shares in the last quarter. Capital Advisors Ltd. LLC lifted its position in shares of Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after acquiring an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. boosted its stake in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares during the period. Moors & Cabot Inc. grew its position in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after purchasing an additional 40 shares in the last quarter. Finally, Harbour Investments Inc. raised its stake in Humana by 10.5% during the 2nd quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after purchasing an additional 41 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Down 2.9 %

HUM opened at $295.49 on Wednesday. The firm has a market cap of $35.58 billion, a P/E ratio of 26.17, a price-to-earnings-growth ratio of 2.35 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business has a 50 day moving average price of $276.28 and a 200 day moving average price of $330.23. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Research analysts forecast that Humana Inc. will post 15.86 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is 31.36%.

Analyst Ratings Changes

HUM has been the topic of a number of research analyst reports. Oppenheimer lowered their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. TD Cowen upped their target price on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Truist Financial lowered their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday, October 11th. Finally, KeyCorp initiated coverage on shares of Humana in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana has a consensus rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.